Miscellaneous
UNIT 14.7 Synthesis of Entecavir and Its Novel Class of Analogs
Published Online: 1 DEC 2011
DOI: 10.1002/0471142700.nc1407s47
Copyright © 2011 by John Wiley & Sons, Inc.
Lab Protocol Title
Current Protocols in Nucleic Acid Chemistry
Additional Information
How to Cite
Rawal, R. K., Singh, U. S., Gadthula, S. and Chu, C. K. 2011. Synthesis of Entecavir and Its Novel Class of Analogs. Current Protocols in Nucleic Acid Chemistry. 47:14.7.1–14.7.17.
Publication History
- Published Online: 1 DEC 2011
- Published Print: DEC 2011
- Abstract
- Article
- Figures
- References
Due to the slow kinetics of viral clearance and the spontaneous genetic variability of hepatitis B virus (HBV), antiviral therapy of chronic hepatitis B remains a clinical challenge. Entecavir (S.10; a 2¢-deoxy carbocyclic guanosine analog with an exo-cyclic double bond on the 5¢-position; Fig. 14.7.1) has been approved in the U.S. for the therapy of chronic hepatitis B. Entecavir is synthesized from d-ribose via a key allylic alcohol (S.3) intermediate. This intermediate is also utilized to synthesize entecavir-modified carbocyclic nucleosides S.13, S.15, S.19, and S.22. Curr. Protoc. Nucleic Acid Chem. 47:14.7.1-14.7.17. © 2011 by John Wiley & Sons, Inc.
Keywords: carbocyclic nucleoside; entecavir; Mannich reaction; Hoffman elimination reaction; Mitsunobu coupling